Summary
Eli Lilly and Company (LLY) filed an 8-K report on April 19, 2011, detailing the outcomes of their annual shareholder meeting held on April 18, 2011. The primary focus of this filing is the voting results on various proposals, which provide insight into shareholder sentiment regarding corporate governance and executive compensation. Key outcomes include the re-election of four directors to three-year terms and the ratification of Ernst & Young LLP as the principal independent auditor. Shareholders also provided an advisory vote on executive compensation and expressed a preference for annual advisory votes on compensation. However, two significant proposals aimed at amending the company's articles of incorporation—one for annual director elections and another to eliminate supermajority voting requirements—did not receive the required 80% of outstanding shares for approval.
Key Highlights
- 1Four nominees for director were successfully elected to serve three-year terms.
- 2Ernst & Young LLP was ratified as Eli Lilly's principal independent auditor.
- 3Shareholders approved an advisory vote on the company's 2010 executive compensation.
- 4An overwhelming majority of shareholders voted in favor of holding advisory votes on executive compensation on an annual basis.
- 5Shareholders did not approve a proposal to amend the articles of incorporation for annual election of directors, as it did not meet the 80% outstanding shares requirement.
- 6Shareholders also did not approve a proposal to eliminate all supermajority voting requirements, which similarly failed to meet the 80% outstanding shares threshold.
- 7The Eli Lilly and Company Executive Officer Incentive Plan was approved by shareholders.